ERBB2 activating variants
Therapeutic response
Precision oncology relationships for therapeutic response involving this biomarker.
Organizations
Biomarkers
Cancer types
Therapies
| Organizations | Biomarkers | Cancer types | Therapies | |
|---|---|---|---|---|
| EMA (1) FDA (2) | ERBB2 activating variants | Non-Small Cell Lung Cancer | Trastuzumab deruxtecan |